ATC code - L01E
SpainProtein kinase inhibitors
Drugs with code L01E
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,40 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Accord Healthcare S.L.U.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,60 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Accord Healthcare S.L.U.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Accord Healthcare S.L.U.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Accord Healthcare S.L.U.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,41 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Laboratorios Cinfa S.A.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,61 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Laboratorios Cinfa S.A.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Reddy Pharma Iberia S.A.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,60 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Reddy Pharma Iberia S.A.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Eugia Pharma (Malta) Limited
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Eugia Pharma (Malta) Limited
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Laboratorio Stada S.L.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Laboratorio Stada S.L.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Teva Pharma S.L.U.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Teva Pharma S.L.U.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,40 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Viatris Limited
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,60 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Viatris Limited
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Zentiva K.S.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Zentiva K.S.
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib 100 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Boehringer Ingelheim International Gmbh
-
Form: capsules, soft gelatin
Active substance Dosage nintedanib 150 mg ATC code: L01E, L01EX, L01EX09
Manufacturer: Boehringer Ingelheim International Gmbh
-
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 121,94 mg ATC code: L01E, L01EJ, L01EJ04
Manufacturer: Glaxosmithkline Trading Services Limited
-
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 182,91 mg ATC code: L01E, L01EJ, L01EJ04
Manufacturer: Glaxosmithkline Trading Services Limited
-
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 243,88 mg ATC code: L01E, L01EJ, L01EJ04
Manufacturer: Glaxosmithkline Trading Services Limited
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 216,70 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Accord Healthcare S.L.U.
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 433,40 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Accord Healthcare S.L.U.
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 216,70 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Reddy Pharma Iberia S.A.
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 433,40 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Reddy Pharma Iberia S.A.
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 216,70 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Glenmark Arzneimittel Gmbh
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 433,40 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Glenmark Arzneimittel Gmbh
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 216,7 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Laboratorio Stada S.L.
-
Form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 433,4 mg ATC code: L01E, L01EX, L01EX03
Manufacturer: Laboratorio Stada S.L.
-
Form: tablets
Active substance Dosage pemigatinib 13,5 mg ATC code: L01E, L01EN, L01EN02
Manufacturer: Incyte Biosciences Distribution B.V.
-
Form: tablets
Active substance Dosage pemigatinib 4,5 mg ATC code: L01E, L01EN, L01EN02
Manufacturer: Incyte Biosciences Distribution B.V.
-
Form: tablets
Active substance Dosage pemigatinib 9 mg ATC code: L01E, L01EN, L01EN02
Manufacturer: Incyte Biosciences Distribution B.V.
-
Form: tablets, film-coated
Active substance Dosage alpelisib 150 mg ATC code: L01E, L01EM, L01EM03
Manufacturer: Novartis Europharm Limited
-
Form: tablets, film-coated
Active substance Dosage alpelisib 200 mg ATC code: L01E, L01EM, L01EM03
Manufacturer: Novartis Europharm Limited
-
Form: tablets, film-coated
Active substance Dosage alpelisib 50 mg alpelisib 200 mg ATC code: L01E, L01EM, L01EM03
Manufacturer: Novartis Europharm Limited
-
Form: tablets
Active substance Dosage ripretinib 50 mg ATC code: L01E, L01EX, L01EX19
Manufacturer: Deciphera Pharmaceuticals (Netherlands) B.V.
-
Form: tablets, film-coated
Active substance Dosage selpercatinib 40 mg ATC code: L01E, L01EX, L01EX22
Manufacturer: Eli Lilly Nederland B.V.
-
Form: tablets, film-coated
Active substance Dosage selpercatinib 80 mg ATC code: L01E, L01EX, L01EX22
Manufacturer: Eli Lilly Nederland B.V.
-
Form: capsules, hard
Active substance Dosage entrectinib 100 mg ATC code: L01E, L01EX, L01EX14
Manufacturer: Roche Registration Gmbh
-
Form: capsules, hard
Active substance Dosage entrectinib 200 mg ATC code: L01E, L01EX, L01EX14
Manufacturer: Roche Registration Gmbh
-
Form: capsules, soft gelatin
Active substance Dosage midostaurin 25,00 mg ATC code: L01E, L01EX, L01EX10
Manufacturer: Novartis Europharm Limited
-
Form: tablets, film-coated
Active substance Dosage asciminib hydrochloride 21,620 mg ATC code: L01E, L01EA, L01EA06
Manufacturer: Novartis Europharm Limited
-
Form: tablets, film-coated
Active substance Dosage asciminib hydrochloride 43,24 mg ATC code: L01E, L01EA, L01EA06
Manufacturer: Novartis Europharm Limited
-
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg ATC code: L01E, L01EX, L01EX02
Manufacturer: Accord Healthcare S.L.U.
-
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg ATC code: L01E, L01EX, L01EX02
Manufacturer: Laboratorio Stada S.L.
-
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 548 mg ATC code: L01E, L01EX, L01EX02
Manufacturer: Laboratorio Stada S.L.
-
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg ATC code: L01E, L01EX, L01EX02
Manufacturer: Teva Pharma S.L.U.
-
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg ATC code: L01E, L01EX, L01EX02
Manufacturer: Viatris Limited